Meyka AI API is live for developers.Start building.
Advertisement
Decision Diagnostics Corp.

Decision Diagnostics Corp. (DECN) Stock Overview

Explore Decision Diagnostics Corp.’s financial performance, market position, analyst ratings, and future outlook.

DECNPNK
HealthcareMedical - Pharmaceuticals
$0.00
$0.00(0.00%)
U.S. Market opens in 46h 30m
Advertisement

Decision Diagnostics Corp. (DECN)

Meyka AI Score

Z

Key Financials

Market Cap35.5K
P/E Ratio-0.00
EPS (TTM)$-0.02
ROE-103.89%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

DECN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Decision Diagnostics Corp. (DECN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 35.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.00%
1-Month Change
0.00%
3-Month Change
0.00%
6-Month Change
9900.00%
Year-to-Date (YTD) Change
9900.00%
1-Year Change
0.00%
3-Year Change
N/A
5-Year Change
-99.23%
All-Time (Max) Change
-100.00%

Contact Information

805 446 1973
2660 Townsgate Road, Westlake Village, CA, 91361

Company Facts

6 Employees
IPO DateFeb 8, 2002
CountryUS
Actively Trading

Frequently Asked Questions